Stock Market News
Latest financial news · Updated Jul 04, 2026
Australia's Firmus Technologies strikes AI access deal with Nvidia
The panel is divided on the Nvidia-Firmus partnership, with concerns about utilization, pricing, and execution risks, particularly around Firmus' ability …
Billionaire Mark Cuban Says Data Center Fight Is ‘Proxy For Hate’ Toward AI And ‘Concentration Of Wealth’ — ‘Nothing To Do With Data Centers’
The panel consensus is that data center opposition, driven by local concerns like noise and grid strain, poses a significant …
‘We should be at $2.25 at the pump’: Trump says Exxon, Chevron, Shell and BP are price gouging drivers. Do you agree?
The panel generally agrees that the political focus on 'gouging' is misplaced, with market mechanics and regional supply constraints driving …
Sandisk Is Crushing Every S&P 500 Stock in 2026. Can Anything Stop It?
The panel consensus is bearish on Sandisk's current valuation, with key risks including rapid supply response to price signals, geopolitical …
This Overlooked AI Infrastructure Stock Could Be 2026's Biggest Winner
The panel has mixed views on Dell's AI infrastructure play. While some see potential in attached services and enterprise demand, …
This Under-the-Radar 4.4% Yielding Stock Is a Top Defensive Refuge for Retirees
The panel consensus is bearish on Donegal Group (DGICA) due to its reliance on investment income, exposure to weather-driven losses, …
Should You Buy Intel Stock After Its Massive AI Rally?
The panel consensus is bearish on Intel's foundry ambitions, citing execution risks, cash flow pressures, and the need for anchor …
Huntington Ingalls Industries vs. Lockheed Martin: Which Industrial Stock Is a Better Buy in 2026?
The panel consensus is bearish on Huntington Ingalls Industries (HII) for 2026, citing its high concentration in Navy contracts (81%), …
Most Investors Have Never Heard of This Industrial Stock. That's About to Change.
The panelists have a neutral to bearish sentiment on EMCOR, highlighting risks such as cyclicality, customer concentration, margin volatility, and …
Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound?
The panel consensus is bearish on Canopy Growth, citing concerns about stagnant recreational growth, international sales decline, and persistent unprofitability …
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
The panel consensus is that the Bridge program for obesity drugs is structurally bullish for Novo Nordisk and Eli Lilly …
Everyone Is Talking About SpaceX. Here Are 2 Growth Stocks I Like Much Better.
The panel is largely bearish on the given article, citing mismatched metrics, speculative valuations, and overlooked risks for SpaceX, MELI, …